DatasetName,MYEF2_S(391) MYEF2_S(431) MYEF2_S(520) MYEF2_S(571) MYEF2_S(6),MYEF2_S(17) MYEF2_T(13)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.5022912729047639,0.6188565750211624
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,0.681106153893091
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.6787778809004947
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,0.6183165499300779
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5032356223598862,0.5757502083026426
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,0.6100065394926154
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,0.6311303890187584
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,0.6021995175895514
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.5033899256560848,0.5769461980218205
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,0.6557112963623357
EP2017_Untreated R#4 normalized log2 ratio,,
WZ2023_Pu_010_30min,,0.7546449365885015
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.7067203709524729
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,0.685354553548937
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,0.666188620438434
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,
AH2018_SILAC_MR_2_N,,0.7092234446188161
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.5202274006072524,0.6211845285432372
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,0.6314202844268564
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,0.5253686024503568
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,0.6194491742351513
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,,0.7583979358619353
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,0.5992379012134894
KBE2022_Log2_Ex_34_U,,0.629587030006425
WZ2023_Pu_005_10min,,0.7549163797748375
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.6609114609929936
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,,0.7529219178988623
AH2018_SILAC_MR_2_X,,0.6987870216490952
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,0.5488740833894237
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,0.561671110982704
CR2017_Ratio Replicate 1.3,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.6599981242756672
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,0.6609426576101274
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,0.5172298735449189,0.556081254079273
AH2018_LFQ_1_C,,0.6943870662694007
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,0.5950255711735674
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,,0.7568758040832799
CK2022_11 40-1,,0.6614145165764335
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.6583546244128865
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,
FSO2013_Ratio H/L normalized Rep2,0.5084365522890986,0.5917182871967139
WZ2023_Pu_005_20min,,0.7596112441650769
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.5486549079983448
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,0.6557378512149787
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.7026878719043634
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,0.6006208934994821
CK2022_1 200-1,,0.6575736974689199
PG2020_Intensity Mock_10h_D,,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.6148750210236995
KBE2022_Log2_Ex_8_T,,0.6161811567557172
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.5199116518878405,0.5782656527848726
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,0.6927248983541837
CK2022_3 40-1,,0.6384372778703962
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,0.5992964749684075
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.5746765031168644
EJN2021_5_Rest_Basal,,0.6202079488585666
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.6628584710651035
YA2020_Reporter_intensity_Normal_No.1,,0.6131542279237623
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,0.5938815666225659
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.5826397114717008
HS2024_8_I_T3,,
CF2017_EOC 3,,0.6238789068793718
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,,0.7522508377044508
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.6371456113038108
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,0.6781405319089897
KS2014_Intensity N3,,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.6743200793032273
FSO2013_Ratio H/M normalized Rep2,0.4842504069945086,0.5567932224895622
RAM2015_Log2 A,,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,0.7068297842879979
KS2014_Intensity E15_2,,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,0.6607605341075544
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,0.5651181356481261
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.6999242430508127
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,0.5984943757453645
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,0.6549818801418544
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,0.6704100149221982
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,0.504224159511678,0.5766385587469156
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,0.682527201710261
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.6951569386808212
DL2023_control-1,,
AR2021_ALG 10 μM,,0.5737883044349976
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.673721977051536
EJN2021_4_Rest_Ins,,0.5960049089744405
RN2012_H05,,0.6245265595004867
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.5238634951751047
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,0.6023679396288435
HH2022_Reporter intensity 3,0.50503248927846,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.6838793952267574
JW2021_After_3,,
GF2025_P8_Sph,,0.6788125708617634
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.6610059317574919
CK2022_11 200-1,,0.6653043500600482
CK2022_12 200-1,,0.661490894855119
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,,0.7572058799214803
AH2018_TMTMS2_2_N,0.5038559145056581,0.6713236891990433
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,0.6267746831384118
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,,0.5851719601195766
KS2014_Intensity N4,,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,0.5724296417483976
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.6618975764770144
CK2022_14 200-1,,0.6980017195634726
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.6004842187312361
AST2020_anti-CD3+PDL2.2,,0.5997044312668204
PG2020_Intensity Mock_10h_A,,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,0.5679585367059041
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,0.6560893508109348
GF2025_P1_Adh,,0.5005638575862831
GF2025_P1_Sph,,0.5467219141358683
EJN2021_5_Ex_Basal,,0.612236866341949
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,,0.7535659170248903
CF2017_EOC 1,,0.6994115277233088
CK2022_3 200-1,,0.662671540461679
AH2018_LFQ_IT_3_C,,0.6638770662097583
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,,0.635683361621918
RB2022_1_PostSprint,,
CK2022_4 200-1,,0.662998555079601
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,0.6806045248046424
AR2021_ALG 1 μM,,0.587301875763963
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,0.5942270429393145
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.654616361552262
CK2022_9 16-1,,0.612551865526024
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,0.6988622196157142
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,
CK2022_16 16-1,,0.6564953883672355
FS2019_db/db3,,
CK2022_15 40-1,,0.6836653706844562
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,0.7513705583014996
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,0.621733053556746
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.6582286486222887
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,,0.5843166770469401
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,0.6269443504169134
AH2018_LFQ_M_1_N,,0.7086236630284668
KBE2022_Log2_Ex_27_U,,0.6592191482202944
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.6745505439206876
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,0.6239492984559585
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,0.6108465322764848
RN2012_L13,,0.6358884504316253
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,0.6095069075109809
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.48792579094522576,0.5651416770210811
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.6636669495972549
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5271539154872507,0.7854370672713489
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.5598873011931265
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5065196618896632,0.6765298826992061
GF2025_P3_Adh,,0.544036752054372
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5032593530641358,0.6683419404394725
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.48980291695604744,0.5480552439851718
KBE2022_Log2_Ex_19_U,,0.6398255937287585
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,0.6587015262852682
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,0.6440171496462881
AST2020_Control,,0.593265252138311
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,0.6602833564049679
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.5040908404819228,0.5764691053663681
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,0.6294928818339417
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,0.6977617766334896
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,
HH2022_Reporter intensity 1,0.5050741237322909,
HH2022_Reporter intensity 2,0.5041787316557024,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,0.6164201218970122
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,,0.6542326567168281
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.4942116319312544,0.6276072996501885
AR2021_KD 72h,,0.6053081769237657
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,0.6373006638391171
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.5796994462315955
KBE2022_Log2_Ex_9_U,,0.6177396164691993
AH2018_SILAC_M_3_N,,0.6625650777472745
KBE2022_Log2_Ex_13_T,,0.6234128913728678
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,
CF2017_OSE 29,,0.6999146133825367
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,
RN2012_L12,0.5508803368694656,0.6416862050680254
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.6645906186765032
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5164649905360437,0.5449259177458485
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.7027295172782844
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,0.5981958051558067
TM2022_S2.12h.B,,
RN2012_L15,0.5300326119938823,0.5791569768577293
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,0.6334000227484899
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,,0.7167378316732544
CK2022_5 200-1,,0.7198647706917372
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,0.6600688860633213
FSO2013_Ratio H/L normalized Rep2___1,0.5086608208185839,0.5922285341907343
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,0.683463280072815
AH2018_SILAC_MR_1_X,,0.6999559988646455
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,0.6659178894462399
AH2018_SILAC_3_C,,0.6647956152572789
EJN2021_5_Rest_Ins,,0.6008355141860726
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.5148789577636499,0.5377940025809588
CK2022_4 16-1,,0.599281252083216
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,0.5912650201659915
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.7025588836973842
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,0.5105292335024018,0.6299701572139222
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,0.6224492429736386
AH2018_SILAC_IT_2_N,,0.6711585650895662
AH2018_SILAC_IT_1_X,,0.6730167851135932
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,0.630082989846249
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.5162118215865412
WZ2023_Pe_025_20min,,0.7527000908487125
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.6862000507478438
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.5096578986698062,0.6732619976267128
RN2012_H06,0.4675911721977002,0.4484147602443687
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,,0.7435025772699384
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,0.6271070061883766
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,0.5476124437659378
WZ2023_Su_025_10min,,0.7620913815826108
AH2018_LFQ_IT_4_X,,0.6598434278849247
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,,0.753662669440337
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,
LY2019_P7+,,0.6469142392495205
EP2017_Untreated R#1 normalized log2 ratio,,
RN2012_L10,0.5087626063757046,0.6012683015240238
PG2020_Intensity 4h_C,,
EP2017_Mitotic R#3 normalized log2 ratio,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,0.628251364638122
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,0.6676817591433607
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,0.540156134631518
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,0.5728730536364318
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,0.6540359358536527
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.6989606578450409
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,
GF2025_P9_Sph,,0.6217671772070812
CK2022_6 200-1,,0.7147430832962234
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.5714528178342407
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,0.5888312633020208
PG2020_Intensity 2h_D,,
EP2017_Untreated R#3 normalized log2 ratio,,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.716479465038235
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,0.6388226560096923
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,0.6615688165177394
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,0.6533666734909727
AH2018_SILAC_2_C,,0.6639044569082952
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,,0.6280981623900557
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,0.5653464167177025
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,0.7178243497151914
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.7056658696384378
PG2020_Intensity CT_C,,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,0.5478942261683077
EP2017_Untreated R#3 log2 ratio,,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.6585475306619535
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,0.6708176937110902
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,0.5375414800993273
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.5403364369368814
YA2020_Reporter_intensity_Normal_No.2,,0.6192400310098464
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.6958528143002094
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,0.6228649688741775
CK2022_2 16-1,,0.584998695786095
RAM2015_Log2 B,,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,0.5870472155300741
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,0.6265460009255382
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,
WZ2023_Su_025_30min,,0.7592400912993766
AH2018_LFQ_4_N,,0.710426768841121
CR2017_Ratio Replicate 1.2,,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,,0.6759692563437798
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,0.5727382502915828
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.6138551538979127
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.5921197357752019
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,0.6526435690472
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.718654515366413
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,
AH2018_LFQ_2_X,,0.6838401349512381
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,,
GF2025_P3_Sph,,0.6236040023185336
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.6785549915696523
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.6756100800990048
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,0.6244548732116711
ZQ2022_N1,,
LY2019_P6-,,0.5927746401441658
RM2024_Intensity D2-3,,
UK2020_HCM_1,,0.6313833052352824
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.4910930686471894,0.5259420285847433
AH2018_LFQ_3_N,,0.6912672353906751
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,0.6265118814349763
KBE2022_Log2_Ex_13_U,,0.6110975798495546
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,0.6632721267805151
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,0.7031663246820206
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,,0.7544860587116013
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.4833110757818257
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,0.6525697271031952
FSO2013_Ratio H/L normalized Rep1,0.5148312757280263,0.5481727701126458
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,0.6618012890338076
CK2022_13 40-1,,0.6818048782398405
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.46534650414854034,0.45401852236060275
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,0.6085716348772918
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,0.6077514840675237
EP2017_Pervanadate R#3 log2 ratio,,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,0.7066720920111611
AH2018_LFQ_M_4_C,,0.7049617766560143
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,0.6511723630925026
RN2012_H04,,0.48967078800137254
CK2022_6 40-1,,0.7038500968385646
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,0.5652308726010247
LY2019_P3-,0.5261397620511857,0.7903910288644691
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,0.5931528378894106
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,,0.752646655856468
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,0.6012076144301075
AST2020_Control.1,,0.5972356705003796
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,,0.7521270633905837
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,0.7204434294426186
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5006652550142903,0.6635987345255632
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,0.5737847040967226
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.6812672852535703
LY2019_P8+,,0.4797951037349935
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.7093043252020537
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,0.6016998113415344
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.6972258278006789
LY2019_P2-,0.47368229847146226,0.5843839398024692
AH2018_LFQ_IT_1_X,,0.6762242821608706
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,,0.7514213997977071
AST2020_Control.2,,0.5940901401242935
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.6378232909196505
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.6558911749724754
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,0.6210965953870049
AH2018_TMTMS3_3_N,,0.5806336932709896
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.7029223360557234
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,
KBE2022_Log2_Ex_36_T,,0.6238894252342487
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,,0.7502412855241306
KS2014_Intensity C2,,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,0.5614406530110604
CK2022_9 200-1,,0.6685536511395813
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.6728092607882836
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.4829844390555145,0.575472190610887
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,0.665282564459637
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,0.6677647743327646
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,0.590218241479969
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,0.546546093539859
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,,0.7596398185882669
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,0.5561174993957669
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,0.659332584363657
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,0.7023349588703347
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.6975079804541237
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.5285793319158852,0.6220609125886278
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,,0.586716609606311
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,0.5915409935846447
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,,0.7527664098473168
KBE2022_Log2_Ex_29_U,,0.6223472967486587
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,0.6938195209721498
AH2018_LFQ_IT_4_N,,0.662646219091156
CK2022_15 200-1,,0.6995807008711821
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,0.6267337634976704
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,0.6706594360020539
LY2019_P2+,0.5338469640882588,0.5830076211957955
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,0.6587339388153354
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,,0.7553628573456932
RN2012_H01,0.4787607602901075,0.6044076238249027
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,0.6111431601184626
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,0.5784938099139814
EP2017_Pervanadate R#1 normalized log2 ratio,,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,0.5948540741674455
KBE2022_Log2_Ex_44_U,,0.6348745874061179
WZ2023_Pe_010_20min,,0.7517307222454761
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,,
FSO2013_Ratio H/M normalized Rep3___1,0.49455739031252877,0.6278095086068545
AH2018_SILAC_M_3_C,,0.664668550167484
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.6638040636721902
AH2018_SILAC_M_2_X,,0.654851108493844
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,0.5368071469922036
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,,0.7575828427981872
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.7003301408903444
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5027988468170184,0.6692080018416808
CK2022_15 16-1,,0.656929591224789
CK2022_3 16-1,,0.5987776583594546
LY2019_P4-,0.4825694537953086,0.5357302443488183
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,,0.6945180295545648
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.6186763597268843
CK2022_10 16-1,,0.6223710766753907
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,0.6266604696262976
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,
EJN2021_2_Ex_Basal,,0.6106706048768938
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,0.6776984608769139
CF2017_FTE 16,,0.7132774371518046
AR2021_L41 10 μM,,0.6582237213077524
CF2017_EOC 2,,0.6787805677327118
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,0.6740144803640828
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,0.6319372605267484
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,0.6790396491127801
ZX2022_CB treated Replicate 1,,0.6126687732497388
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.503918230589687,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5055209419701968,0.6671447137230431
AR2021_L41 1 μM,,0.6259055365785966
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5029614468703609,0.6742981699733179
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,0.6174129760957099
KS2014_Intensity C4,,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,0.647340924509291
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.7011703677807972
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,0.6577211944136592
YA2020_Reporter_intensity_Cancer_No.2,,0.6126852020471232
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,0.6766618445808008
WZ2023_Pu_025_10min,,0.7624894395214992
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.5019498182168759,0.6174743431538019
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,0.6158054716645474
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,,0.7523042896730918
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.6610254960699105
KS2014_Intensity C6,,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.6607714023380182
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.6264971731775206
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,0.6856164095686563
AH2018_SILAC_IT_2_C,,0.6784093507612635
CK2022_5 40-1,,0.7048908767050335
AH2018_LFQ_3_X,,0.6935562951929157
UK2020_UA_3,,0.6254408167487944
LY2019_P7-,,0.6743310357068537
GF2025_P5_Adh,,0.49133130088388177
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.510757525155179,0.630590444054187
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,0.6258992416424298
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,,0.6679460456983028
PG2020_Intensity CT_B,,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.7050631240665559
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,0.6912654110785804
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.7029431072640762
YA2020_Reporter_intensity_Cancer_No.4,,0.5906267852276577
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.5877522024130153
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,0.657671241992414
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,0.658367681679651
AST2020_anti-CD3+PDL2,,0.5934543617094481
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,0.6095465934701132
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,
AH2018_TMTMS2_1_X,0.5057187255251859,0.6773132164480935
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,0.5865445883794622
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.6961312063612288
HS2024_4_I_T3,,
AH2018_SILAC_1_X,,0.6758514497099348
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,,0.5924408863155987
CF2017_FTE 14,,0.7146758397290436
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,0.6683510096176569
EP2017_Untreated R#2 normalized log2 ratio,,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.6322701099955205
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,
AS2011_Ratio H/L Normalized RNAi_2_1,,
